Gold prices hit 2-week high as Trump-Fed feud escalates with Cook firing
Investing.com - Wave Life Sciences Ltd reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Wave Life Sciences Ltd announced earnings per share of $-0.420 on revenue of $290K. Analysts polled by Investing.com EPS of $-0.480 on revenue of $8.73M.
Wave Life Sciences Ltd 's are down 24% and is trading at $3.950 , still down 25.80% from its 52 week high of $5.31 set on Monday, October 17, 2022.
Wave Life Sciences Ltd shares gained 0.25% to trade at $3.950 in pre-market trade the report.
Wave Life Sciences Ltd follows other major Healthcare sector earnings this month
Wave Life Sciences Ltd's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar